Recent advances in theranostic nanomaterials for overcoming traumatic brain injury
- 문서 유형
- 연구출판물 · 리뷰논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q1Scopus Q1
- 저널
- JOURNAL OF NANOBIOTECHNOLOGY23(1) · #692 · 2025
- 피인용
- Web of Science 13Scopus 15
- FWCI (Scopus)
- 0.88
- JCR IF
- JCR 2024 12.6
- ISSN
- 1477-3155
저자
- Hwang, Nam Cheol제1저자Kyung Hee Univ, Grad Sch, Dept Biomed Sci, Seoul 02447, South Korea
- 임동민Pusan Natl Univ, Interdisciplinary Program Genom Data Sci, Yangsan 50612, South Korea
- 고태식Pusan Natl Univ Hosp, Biomed Res Inst, Busan 49241, South Korea
- 강정모Pusan Natl Univ Hosp, Biomed Res Inst, Busan 49241, South Korea
- Kim, JaehoonKyung Hee Univ, Coll Med, Seoul 02447, South Korea
- Kim, Shin교신저자Keimyung Univ, Sch Med, Dept Immunol, Daegu 42601, South Korea
- 김윤학교신저자Pusan Natl Univ, Sch Med, Dept Anat, Yangsan 50612, South Korea
- Kim, Dokyoung교신저자Kyung Hee Univ, Grad Sch, Dept Biomed Sci, Seoul 02447, South Korea
초록
Traumatic brain injury (TBI) is a major global health challenge characterized by complex secondary injury mechanisms involving oxidative stress, inflammation, and blood-brain barrier (BBB) disruption. Traditional biosensing and therapy strategies often face limitations due to ineffective biomarker detection and poor drug targeting at the injury site. Recently, theranostic nanomaterials have emerged as a promising solution, integrating diagnostic and therapeutic functionalities within a single nanoscale platform. This review explores the latest advances in nanotherapeutics and nanosensors for TBI management. The first section summarizes various nanotherapeutic approaches, including PEGylated-polystyrene nanoparticles, porous silicon nanoparticles, carbon dot nanoparticles, dendrimer nanoparticles, lipid nanoparticles (LNPs), and siRNA-based nanoparticles, all of which have demonstrated enhanced neuroprotection and targeted drug delivery in TBIs. Notably, LNPs exhibit further optimized biocompatibility and therapeutic efficacy, while carbon dot nanoparticles function as nanozymes to combat oxidative stress, thereby mitigating neuronal damage. The second section focuses on nanosensors for TBIs, including peptide-based nanosensors, ECM-targeted nanosensors, and biomarker-responsive platforms capable of real-time diagnosis and monitoring of TBI progression. Additionally, the use of polymeric and fibrinogen-based nanosensors is discussed as advanced strategies to improve precision detection and therapeutic control. This review provides a comprehensive overview of theranostic nanomaterials for TBIs, highlighting their transformative potential in diagnosis and targeted treatment, while addressing key translational challenges to clinical application.
키워드
BrainNanotherapeuticsDrug deliveryTranslational researchBiomedical engineeringCONTROLLED CORTICAL IMPACTCLINICAL-TRIALTHERAPEUTIC TARGETOXIDATIVE STRESSOLDER-ADULTSMOUSE MODELRAT MODELCALPAINBARRIERPROGESTERONE
식별자
- Scopus EID
- 2-s2.0-105020259194
- WoS UID
- 001603121500001



로그인
연구물 목록으로